What Device Manufacturers Can Learn From FDA’s Inspection Data

Companies in China, Germany and the United Kingdom should take heed, as they are the companies most often getting OAIs. Read More

EMA’s PRAC Recommends Restricting Zinbryta Use to Certain MS Patients

Patients with liver injury must not be given the medicine, according to the EMA’s Pharmacovigilance Risk Assessment Committee. Read More
The Solutions Center